Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Vivoryon Therapeutics N.V. buy melinda

Vivoryon Therapeutics N.V.
Start price
€11.80
26.11.17 / 50%
Target price
€17.00
16.01.18
Performance (%)
23.74%
End price
€14.60
16.01.18
Summary
This prediction ended on 16.01.18 with a price of €14.60. The prediction had a final performance of 23.74%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Vivoryon Therapeutics N.V. -5.507% -5.507% -33.672% -90.944%
iShares Core DAX® -4,93 % -11,98 % -3,49 % 44,54 %
iShares Nasdaq 100 -2,63 % -2,22 % 13,78 % 80,99 %
iShares Nikkei 225® -4,73 % -10,90 % 19,71 % 45,26 %
iShares S&P 500 -2,54 % -3,54 % 8,88 % 61,12 %

According to melinda what are the pros and cons of Vivoryon Therapeutics N.V. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Vivoryon Therapeutics AG diskutieren
Prediction Buy
Perf. (%) 23.74%
Target price 17.000
Change
Ends at 16.01.18

Biotechnologie und Medizintechnik SecteurRecherche Agenda 27/11 | 02.00 Präsentation



Firmenprofil
Probiodrug ist auf die Erforschung und Entwicklung von therapeutischen Produkten für die Behandlung der Alzheimer-Krankheit. Am Ende 2016 hat die Gruppe einen Portfolio von Produkten 2 in der vorklinischen Entwicklung (PBD-C06 und PQ1565) und ein Produkt in der Phase IIa



melinda 
0
Report Share
26.11.17
Prediction Buy
Perf. (%) 23.74%
Target price 17.000
Change
Ends at 16.01.18

(Vom Mitglied beendet)

melinda 
0
Report Share
16.01.18

Stopped prediction by melinda for Vivoryon Therapeutics N.V.

buy
Vivoryon Therapeutics N.V.

Start price
Target price
Perf. (%)
€18.36
27.11.21
€19.00
27.11.22
-50.44%
28.11.22

Could be worthwhile Investment >10% per year
melinda 
27.11.21 50%
buy
Vivoryon Therapeutics N.V.

Start price
Target price
Perf. (%)
€3.80
16.03.20
€5.00
04.11.21
437.55%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
16.03.20 50%
buy
Vivoryon Therapeutics N.V.

Start price
Target price
Perf. (%)
€5.48
26.02.20
€7.50
16.03.20
-30.75%
16.03.20

Could be worthwhile Investment >10% per year
melinda 
26.02.20 50%
buy
Vivoryon Therapeutics N.V.

Start price
Target price
Perf. (%)
€11.80
26.11.17
€17.00
16.01.18
23.74%
16.01.18

Could be worthwhile Investment >10% per year
melinda 
14.08.19 50%